The Lancet: New studies show that 2 classes of inexpensive generic drugs can reduce breast cancer deaths
Two new studies, both published in The Lancet, suggest that two different classes of drugs, aromatase inhibitors (AIs) and bisphosphonates, can each improve survival prospects for postmenopausal women with early breast cancer. Moreover, the researchers suggest that the two types of drug can be used together, increasing the benefits while also decreasing some side-effects.
Most women are post-menopausal when they develop breast cancer, and breast cancer is usually found early, when surgery can remove all detectable disease, but might leave dangerous undetected micrometastases ...







